HOOK - Hookipa Pharma - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

HOOK is currently covered by 5 analysts with an average price target of $4.72. This is a potential upside of $3.91 (482.72%) from yesterday's end of day stock price of $0.81.

Hookipa Pharma's activity chart (see below) currently has 21 price targets and 25 ratings on display. The stock rating distribution of HOOK is 90% BUY and 10% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 20.83% with an average time for these price targets to be met of 34.83 days.

Highest price target for HOOK is $5, Lowest price target is $2.25, average price target is $4.72.

Most recent stock forecast was given by BRIAN ABRAHAMS from RBC on 30-Jan-2024. First documented stock forecast 13-May-2019.

Currently out of the existing stock ratings of HOOK, 9 are a BUY (90%), 1 are a HOLD (10%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

5

$4.36 (681.25%)

2 months 20 days ago

0/7 (0%)

$4.39 (719.67%)

Hold

2.25

$1.61 (251.56%)

6

10 months 14 days ago

1/4 (25%)

$1.09 (93.97%)

40

Buy

4

$3.36 (525.00%)

1 years 30 days ago

0/3 (0%)

$3.19 (393.83%)

Buy

3

$2.36 (368.75%)

4

1 years 8 months 8 days ago

0/4 (0%)

$1.41 (88.68%)

Buy

8

$7.36 (1150.00%)

15

2 years 2 months 2 days ago

0/2 (0%)

$6 (300.00%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is HOOK (Hookipa Pharma) average time for price targets to be met?

On average it took 34.83 days on average for the stock forecasts to be realized with a an average price target met ratio 20.83

Which analyst has the current highest performing score on HOOK (Hookipa Pharma) with a proven track record?

BRIAN ABRAHAMS

Which analyst has the current lower performing score on HOOK (Hookipa Pharma) with a proven track record?

SWAYAMPAKULA RAMAKANTH

Which analyst has the most public recommendations on HOOK (Hookipa Pharma)?

Brian Abrahams works at RBC and has 17 price targets and 13 ratings on HOOK

Which analyst is the currently most bullish on HOOK (Hookipa Pharma)?

Swayampakula Ramakanth with highest potential upside - $7.36

Which analyst is the currently most reserved on HOOK (Hookipa Pharma)?

Roy Buchanan with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?